ID   GPT_HUMAN               Reviewed;         408 AA.
AC   Q9H3H5; O15216; Q86WV9; Q9BWE6;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2001, sequence version 2.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase;
DE            EC=2.7.8.15;
DE   AltName: Full=GlcNAc-1-P transferase;
DE            Short=G1PT;
DE            Short=GPT;
DE   AltName: Full=N-acetylglucosamine-1-phosphate transferase;
GN   Name=DPAGT1; Synonyms=DPAGT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=9451016; DOI=10.1093/glycob/8.1.77;
RA   Eckert V., Blank M., Mazhari-Tabrizi R., Mumberg D., Funk M.,
RA   Schwarz R.T.;
RT   "Cloning and functional expression of the human GlcNAc-1-P
RT   transferase, the enzyme for the committed step of the dolichol cycle,
RT   by heterologous complementation in Saccharomyces cerevisiae.";
RL   Glycobiology 8:77-85(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Dagnino F., Regis S., Filocamo M., Gatti R.;
RT   "Putative genomic sequence of GlcNAc-1-P transferase on chromosome
RT   11q23.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   VAL-393.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT CDG1J CYS-170.
RX   PubMed=12872255; DOI=10.1002/humu.10239;
RA   Wu X., Rush J.S., Karaoglu D., Krasnewich D., Lubinsky M.S.,
RA   Waechter C.J., Gilmore R., Freeze H.H.;
RT   "Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1
RT   phosphate transferase (DPAGT1) causes a novel congenital disorder of
RT   glycosylation type Ij.";
RL   Hum. Mutat. 22:144-150(2003).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-9.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [7]
RP   VARIANTS CMS13 ILE-108; ILE-117; MET-120; SER-160; SER-192 AND
RP   GLY-264.
RX   PubMed=22742743; DOI=10.1016/j.ajhg.2012.05.022;
RA   Belaya K., Finlayson S., Slater C.R., Cossins J., Liu W.W.,
RA   Maxwell S., McGowan S.J., Maslau S., Twigg S.R., Walls T.J.,
RA   Pascual Pascual S.I., Palace J., Beeson D.;
RT   "Mutations in DPAGT1 cause a limb-girdle congenital myasthenic
RT   syndrome with tubular aggregates.";
RL   Am. J. Hum. Genet. 91:193-201(2012).
CC   -!- FUNCTION: Catalyzes the initial step in the synthesis of dolichol-
CC       P-P-oligosaccharides.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-glucosamine + dolichyl
CC       phosphate = UMP + N-acetyl-D-glucosaminyl-diphosphodolichol.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9H3H5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H3H5-2; Sequence=VSP_001803;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9H3H5-3; Sequence=VSP_008886;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Congenital disorder of glycosylation 1J (CDG1J)
CC       [MIM:608093]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:12872255}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]:
CC       A form of congenital myasthenic syndrome, a group of disorders
CC       characterized by failure of neuromuscular transmission, including
CC       pre-synaptic, synaptic, and post-synaptic disorders that are not
CC       of autoimmune origin. Clinical features are easy fatigability and
CC       muscle weakness. CMS13 is characterized by muscle weakness mostly
CC       affecting proximal limb muscles, minimal involvement of facial,
CC       ocular and bulbar muscles, and tubular aggregates present on
CC       muscle biopsy. Symptoms include difficulty walking and frequent
CC       falls. Younger patients show hypotonia and poor head control.
CC       Neurophysiological features indicate a disorder of neuromuscular
CC       transmission on electromyography. {ECO:0000269|PubMed:22742743}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 4 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=UDP-
CC       N-acetylglucosamine--dolichyl-phosphate N-
CC       acetylglucosaminephosphotransferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_543";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z82022; CAB04787.1; -; mRNA.
DR   EMBL; AF070443; AAG43168.1; -; Genomic_DNA.
DR   EMBL; AF069061; AAG43168.1; JOINED; Genomic_DNA.
DR   EMBL; BT006802; AAP35448.1; -; mRNA.
DR   EMBL; BC000325; AAH00325.1; -; mRNA.
DR   EMBL; BC047771; AAH47771.1; -; mRNA.
DR   CCDS; CCDS8411.1; -. [Q9H3H5-1]
DR   RefSeq; NP_001373.2; NM_001382.3. [Q9H3H5-1]
DR   RefSeq; XP_016872782.1; XM_017017293.1. [Q9H3H5-3]
DR   UniGene; Hs.524081; -.
DR   PDB; 5LEV; X-ray; 3.20 A; A=1-408.
DR   PDBsum; 5LEV; -.
DR   ProteinModelPortal; Q9H3H5; -.
DR   SMR; Q9H3H5; -.
DR   BioGrid; 108133; 10.
DR   IntAct; Q9H3H5; 1.
DR   STRING; 9606.ENSP00000346142; -.
DR   iPTMnet; Q9H3H5; -.
DR   PhosphoSitePlus; Q9H3H5; -.
DR   BioMuta; DPAGT1; -.
DR   DMDM; 18202943; -.
DR   EPD; Q9H3H5; -.
DR   MaxQB; Q9H3H5; -.
DR   PaxDb; Q9H3H5; -.
DR   PeptideAtlas; Q9H3H5; -.
DR   PRIDE; Q9H3H5; -.
DR   DNASU; 1798; -.
DR   Ensembl; ENST00000354202; ENSP00000346142; ENSG00000172269. [Q9H3H5-1]
DR   Ensembl; ENST00000409993; ENSP00000386597; ENSG00000172269. [Q9H3H5-1]
DR   GeneID; 1798; -.
DR   KEGG; hsa:1798; -.
DR   UCSC; uc001pvi.4; human. [Q9H3H5-1]
DR   CTD; 1798; -.
DR   DisGeNET; 1798; -.
DR   GeneCards; DPAGT1; -.
DR   GeneReviews; DPAGT1; -.
DR   H-InvDB; HIX0019316; -.
DR   HGNC; HGNC:2995; DPAGT1.
DR   HPA; HPA053878; -.
DR   MalaCards; DPAGT1; -.
DR   MIM; 191350; gene.
DR   MIM; 608093; phenotype.
DR   MIM; 614750; phenotype.
DR   neXtProt; NX_Q9H3H5; -.
DR   OpenTargets; ENSG00000172269; -.
DR   Orphanet; 353327; Congenital myasthenic syndromes with glycosylation defect.
DR   Orphanet; 86309; DPAGT1-CDG.
DR   PharmGKB; PA27460; -.
DR   eggNOG; KOG2788; Eukaryota.
DR   eggNOG; COG0472; LUCA.
DR   GeneTree; ENSGT00390000011424; -.
DR   HOGENOM; HOG000163915; -.
DR   HOVERGEN; HBG000846; -.
DR   InParanoid; Q9H3H5; -.
DR   KO; K01001; -.
DR   OMA; WAFPELP; -.
DR   OrthoDB; EOG091G0A0M; -.
DR   PhylomeDB; Q9H3H5; -.
DR   TreeFam; TF313734; -.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; DPAGT1; -.
DR   GenomeRNAi; 1798; -.
DR   PRO; PR:Q9H3H5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172269; -.
DR   CleanEx; HS_DPAGT1; -.
DR   ExpressionAtlas; Q9H3H5; baseline and differential.
DR   Genevisible; Q9H3H5; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008963; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; IEA:InterPro.
DR   GO; GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW.
DR   GO; GO:0003975; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; IDA:UniProtKB.
DR   GO; GO:0003976; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; IDA:MGI.
DR   GO; GO:0019348; P:dolichol metabolic process; IEA:Ensembl.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome.
DR   GO; GO:0006489; P:dolichyl diphosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IMP:UniProtKB.
DR   GO; GO:0051259; P:protein oligomerization; ISS:UniProtKB.
DR   GO; GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IEA:Ensembl.
DR   CDD; cd06855; GT_GPT_euk; 1.
DR   InterPro; IPR000715; Glycosyl_transferase_4.
DR   InterPro; IPR033895; GPT.
DR   PANTHER; PTHR10571; PTHR10571; 1.
DR   Pfam; PF00953; Glycos_transf_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Congenital myasthenic syndrome;
KW   Disease mutation; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Membrane; Polymorphism; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    408       UDP-N-acetylglucosamine--dolichyl-
FT                                phosphate N-
FT                                acetylglucosaminephosphotransferase.
FT                                /FTId=PRO_0000108761.
FT   TOPO_DOM      1      6       Lumenal. {ECO:0000255}.
FT   TRANSMEM      7     32       Helical. {ECO:0000255}.
FT   TOPO_DOM     33     57       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     58     79       Helical. {ECO:0000255}.
FT   TOPO_DOM     80     94       Lumenal. {ECO:0000255}.
FT   TRANSMEM     95    114       Helical. {ECO:0000255}.
FT   TOPO_DOM    115    125       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    126    145       Helical. {ECO:0000255}.
FT   TOPO_DOM    146    164       Lumenal. {ECO:0000255}.
FT   TRANSMEM    165    184       Helical. {ECO:0000255}.
FT   TOPO_DOM    185    194       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    195    211       Helical. {ECO:0000255}.
FT   TOPO_DOM    212    221       Lumenal. {ECO:0000255}.
FT   TRANSMEM    222    240       Helical. {ECO:0000255}.
FT   TOPO_DOM    241    252       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    253    269       Helical. {ECO:0000255}.
FT   TOPO_DOM    270    274       Lumenal. {ECO:0000255}.
FT   TRANSMEM    275    294       Helical. {ECO:0000255}.
FT   TOPO_DOM    295    378       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    379    397       Helical. {ECO:0000255}.
FT   TOPO_DOM    398    408       Lumenal. {ECO:0000255}.
FT   MOTIF        67     79       Dolichol recognition.
FT   MOTIF       222    234       Dolichol recognition.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    107       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008886.
FT   VAR_SEQ       1      8       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9451016}.
FT                                /FTId=VSP_001803.
FT   VARIANT       9      9       M -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036422.
FT   VARIANT     108    108       M -> I (in CMS13; dbSNP:rs376039938).
FT                                {ECO:0000269|PubMed:22742743}.
FT                                /FTId=VAR_068810.
FT   VARIANT     117    117       V -> I (in CMS13; dbSNP:rs387907243).
FT                                {ECO:0000269|PubMed:22742743}.
FT                                /FTId=VAR_068811.
FT   VARIANT     120    120       L -> M (in CMS13; dbSNP:rs387907244).
FT                                {ECO:0000269|PubMed:22742743}.
FT                                /FTId=VAR_068812.
FT   VARIANT     160    160       G -> S (in CMS13; dbSNP:rs762676399).
FT                                {ECO:0000269|PubMed:22742743}.
FT                                /FTId=VAR_068813.
FT   VARIANT     170    170       Y -> C (in CDG1J; dbSNP:rs28934876).
FT                                {ECO:0000269|PubMed:12872255}.
FT                                /FTId=VAR_017243.
FT   VARIANT     192    192       G -> S (in CMS13; dbSNP:rs768464558).
FT                                {ECO:0000269|PubMed:22742743}.
FT                                /FTId=VAR_068814.
FT   VARIANT     264    264       V -> G (in CMS13; dbSNP:rs387907245).
FT                                {ECO:0000269|PubMed:22742743}.
FT                                /FTId=VAR_068815.
FT   VARIANT     393    393       I -> V (in dbSNP:rs643788).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_011391.
FT   CONFLICT     33     33       R -> L (in Ref. 1; CAB04787).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       P -> H (in Ref. 2; AAG43168).
FT                                {ECO:0000305}.
FT   HELIX         9     31       {ECO:0000244|PDB:5LEV}.
FT   HELIX        33     38       {ECO:0000244|PDB:5LEV}.
FT   HELIX        59     73       {ECO:0000244|PDB:5LEV}.
FT   HELIX        75     78       {ECO:0000244|PDB:5LEV}.
FT   HELIX        92    118       {ECO:0000244|PDB:5LEV}.
FT   HELIX       122    132       {ECO:0000244|PDB:5LEV}.
FT   HELIX       134    142       {ECO:0000244|PDB:5LEV}.
FT   HELIX       167    186       {ECO:0000244|PDB:5LEV}.
FT   HELIX       193    211       {ECO:0000244|PDB:5LEV}.
FT   STRAND      214    216       {ECO:0000244|PDB:5LEV}.
FT   HELIX       219    242       {ECO:0000244|PDB:5LEV}.
FT   STRAND      243    245       {ECO:0000244|PDB:5LEV}.
FT   HELIX       251    268       {ECO:0000244|PDB:5LEV}.
FT   HELIX       272    276       {ECO:0000244|PDB:5LEV}.
FT   TURN        277    279       {ECO:0000244|PDB:5LEV}.
FT   HELIX       280    293       {ECO:0000244|PDB:5LEV}.
FT   TURN        309    311       {ECO:0000244|PDB:5LEV}.
FT   STRAND      313    315       {ECO:0000244|PDB:5LEV}.
FT   STRAND      318    322       {ECO:0000244|PDB:5LEV}.
FT   TURN        323    325       {ECO:0000244|PDB:5LEV}.
FT   HELIX       328    339       {ECO:0000244|PDB:5LEV}.
FT   STRAND      345    349       {ECO:0000244|PDB:5LEV}.
FT   STRAND      354    359       {ECO:0000244|PDB:5LEV}.
FT   HELIX       363    371       {ECO:0000244|PDB:5LEV}.
FT   HELIX       376    399       {ECO:0000244|PDB:5LEV}.
SQ   SEQUENCE   408 AA;  46090 MW;  0AE10EFE55E7B9E0 CRC64;
     MWAFSELPMP LLINLIVSLL GFVATVTLIP AFRGHFIAAR LCGQDLNKTS RQQIPESQGV
     ISGAVFLIIL FCFIPFPFLN CFVKEQCKAF PHHEFVALIG ALLAICCMIF LGFADDVLNL
     RWRHKLLLPT AASLPLLMVY FTNFGNTTIV VPKPFRPILG LHLDLGILYY VYMGLLAVFC
     TNAINILAGI NGLEAGQSLV ISASIIVFNL VELEGDCRDD HVFSLYFMIP FFFTTLGLLY
     HNWYPSRVFV GDTFCYFAGM TFAVVGILGH FSKTMLLFFM PQVFNFLYSL PQLLHIIPCP
     RHRIPRLNIK TGKLEMSYSK FKTKSLSFLG TFILKVAESL QLVTVHQSET EDGEFTECNN
     MTLINLLLKV LGPIHERNLT LLLLLLQILG SAITFSIRYQ LVRLFYDV
//
